# Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)

> **NCT03414918** · NA · UNKNOWN · sponsor: **University Hospital Padova** · enrollment: 342 (estimated)

## Conditions studied

- Hyperaldosteronism

## Interventions

- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT03414918
- **Lead sponsor:** University Hospital Padova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 342 (ESTIMATED)
- **Last updated:** 2018-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03414918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03414918, "Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03414918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*